Simon Mackay is Professor of Medicinal Chemistry in the Strathclyde Institute of Pharmacy and Biomedical Science. Simon has 25 years’ experience of research and teaching in the application of medicinal chemistry to drug discovery. He is a graduate of the University of Bath (BPharm (Hons); 1984) and the University of Manchester (PhD Medicinal Chemistry; 1990). His primary research interest is cancer drug discovery, and he is the Principal Investigator for a £3.0M CRUK-funded programme to identify small molecule inhibitors for the treatment of prostate cancer. He is also involved in a kinesin drug discovery project with collaborators at UCL to identify new Eg5 inhibitors.   He has led the medicinal chemistry team for a number of industry-funded drug discovery projects, including the identification of non-steroidal neuroprotective compounds for Hunter-Fleming, PTP1B inhibitors for Kyorin Pharmaceutical and the £9.3M drug discovery programme targeting the Ubiquitin Proteasome System, funded by Scottish Enterprise.